Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

FLAVIVACCINE

Financiado

Development and characterization of a pan-flavivirus vaccine candidate

Dengue, yellow fever, Zika, and West Nile viruses are mosquito-borne flaviviruses and global public health burdens that infect half a billion people annually, causing 250,000 deaths, and threaten nearly the entire human population... ver más

31/12/2027

IRD

8M€

Presupuesto del proyecto: 8M€

Líder del proyecto

INSTITUT DE RECHERCHE POUR LE DEVELOPPEMENT No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Ver 10 Participantes

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2023-12-13

HORIZON-HLTH-2023-DISEASE-03-18: Pandemic preparedness and response:... ExpectedOutcome:This topic aims at supporting activities that are enabling or contributing to one or...

I+D

Cerrada hace 1 año

0% 100%

10 Participantes

IRD

1.78M€ | Lider

ICONS

320.00K€ | Participante

CEA

1.15M€ | Participante

CSIC

1.23M€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

Yellow4FLAVI Deconstructing the protective immunity of yellow fever virus... 8M€ Cerrado

PCI2023-143416 Inmunidad, infección e inmunoterapia 133K€ Cerrado

PID2019-106068GB-I00 DESCIFRANDO EL PAPEL BIOLOGICO DE LOS FACTORES CELULARES QUE... 169K€ Cerrado

LWNVIVAT Limiting West Nile Virus impact by novel vaccines and therap... 6M€ Cerrado

ATLAS The first broad-spectrum treatment against pandemic-prone fl... 14M€ Cerrado

FILOVAX Development of Broadly Protective Filovirus Vaccines 50M€ Cerrado

Duración del proyecto: 48 meses Fecha Inicio: 2023-12-13
Fecha Fin: 2027-12-31

Líder del proyecto

INSTITUT DE RECHERCHE POUR LE DEVELOPPEMENT No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 8M€

Descripción del proyecto Dengue, yellow fever, Zika, and West Nile viruses are mosquito-borne flaviviruses and global public health burdens that infect half a billion people annually, causing 250,000 deaths, and threaten nearly the entire human population. In a context of human-driven global changes, these threats will intensify with larger and more frequent epidemics, potentially leading to pandemics, will expand with geographic spreading of the mosquito vectors, and will multiply with the likely emergence of yet-unknown flaviviruses. Improving pandemic preparedness and response to these emerging and re-emerging diseases is a top priority both for the EU and WHO. However, there are no effective interventions against all flaviviruses and current vaccines targeting flaviviral proteins have severe safety issues. FLAVIVACCINE’s high-impact/low-risk/disruptive ambition is to develop a novel, broad-spectrum, mosquito saliva-targeted vaccine candidate that protects against multiple different flaviviruses and is ready for clinical evaluation by building upon an experimentally-validated proof-of-concept. FLAVIVACCINE will define the immunogenicity of the pan-flavivirus target, develop and characterize a vaccine candidate against multiple flaviviruses, and prepare it for clinical evaluation. To reach these goals, FLAVIVACCINE creates a unique interdisciplinary environment of ten public and private institutions, including Universities, Research Institutions and a Vaccine Developer, from seven countries to cover all the required scientific expertise and knowledge in cell biology, virology, immunology and vaccinology. The pan-flavivirus vaccine candidate that will be validated against dengue, yellow fever, Zika and West Nile diseases in several preclinical models, together with the knowledge and networks resulting from FLAVIVACCINE, will have short- and long-term impact on the EU ability to combat epidemic and pandemic viral threats, and protect communities and citizens in the EU and around the world.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores